CLIN. CHEM. 34/3, 563-567 (1988) 10. Mueller PS,Evans WH. Responseof plasmaglycerol concentrations to epinephrine, norepinephrine, glucose, insulin and prolonged fasting in man. J Lab Clin Med 1963;61:953- g/L, measured concentrations were often registered as negative results. However, these negative values could be replicated to within ± 10 g/L, indicating good precision of the method, but obviously not good accuracy. In addition, lowerthan-expected lead (Pb) values were measured in samples containing increased concentrations of copper (Cu), such as may occur in pregnant women. We modified the procedure to eliminate these inaccuracies by substituting manual peakheight measurements for reliance on the integrator and digital display of the instrument. We established the accuracy of the modified procedure by using calibration standards previously quantified by isotope dilution-mass spectroscopy. A quality-control program for monitoring PbB analysis is also described.
The toxic effects of lead (Pb) on biological systems have been well documented (1), and measurement of blood lead (PbB) concentrations is generally accepted as the best index to current Pb exposure (2).' Numerous analytical methods are available for the measurement of PbB (3,4). However, it is important that accuracy and precision be well established and frequently monitored, to ensure the adequacy of the method used. Here we report our evaluation of the accuracy and precision of PbB measurements by anodic stripping voltammetry (ASV) with a commercially available instrument.
In ASV, metal ions are plated onto a test electrode by using a negative potential, then stripped off the electrode by reversing to an anodic potential, which is varied linearly. The current generated during this removal can be displayed as a gaussian peak on a strip-chart recorder and is a Department of Environmental Health, University of Cincinnati Medical Center, 3223 Eden Ave., Cincinnati, OH 45267-0056.
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function of the amount of metal plated during an already known period of time. Consequently, peak area or height can be related to those for standards of known concentrations to quantify the amount of Pb present in a blood sample.
Within the ASV instrument we routinely use, an electronic module controls the analytical cycles, including a staircase stripping voltage function during which peak signals are integrated. The integration technique used in calculating results from peak current is called "trapezoidal baseline calibration" (5). The area under the peak is quantified by registering the current at the beginning and end of a peak to construct a baseline for the peak integral, then summing the signals from each of the steps within the integration zone. The resulting value should be proportional to the concentration of the sample.
In our experience, analysis for PbB with this ASV analyzer, operated according to the manufacturer's operating manual and conditions, consistently resulted in underestimations of low PbB concentrations and overestimations of higher PbB concentrations (see Results). The most likely cause of these inaccuracies was thought to be limitations of the instrument's integrator, in that computation begins and ends at pre-set invariable points, regardless of where the ionizationpotentialof a metal might initiate current changes. Moreover, because the width of the peak varies as the peak height varies,establishment of the baselineby the integrator may be erroneous. As the instrument is currently set up, when the metal concentration deviates from the range for which the arbitraryintegration zone was established, more or less area is subtracted from the area under the peak, potentially leading to under-or overestimation of concentrations. At low PbB (<50 pg/L) a measured concentration can even be registered as a negative result.
Because ASV has been previously shown, by comparison with a definitive method (6) , to be a precise and accurate technique for PbB measurements, we took these preliminary observations of instrument performance as an indication of the need to evaluate and modify the recommended operating conditions to improve the accuracy of PbB measurements. Accordingly, we altered the recommended procedure, and related the modified ASV Pb procedure to the definitive method for Pb (isotope dilution-mass spectroscopy, ID-MS) (6) by using calibration standards whose Pb concentrations had been previously determined by ID-MS. connected to a Recordall#{174} Series 5000 strip chart recorder (Fisher Scientific, Fair Lawn, NJ) to determine Pb in blood. This instrument is an anodic stripping voltammeter with a mercury-coated graphite electrode, Ag/AgC1 reference electrode, and platinum counter electrode. The plating and stripping cycles are totally automated. Sample preparation involves placing 100 4 of whole blood into 2.9 mL of a metal-exchange reagent, all of which is mixed in the same cell that is used for the analysis. Instrument calibration is based on only two calibration standards provided by the manufacturer ("LO," 20-70 gfL, and "HI," 950-1020 gfL). The currents generated from these standards are evaluated by using an internal integrator. The results are displayed on a digital output (5). For comparison of Pb measurements of split samples and for the assay of serum copper (Cu), we used an atomic absorption spectrophotometer (Model 5000; Perkin Elmer Corp., Norwalk, CT 06856).
Materials and Methods

Apparatus
Instrument settings. Table 1 lists instrument settings for both the method recommended by the manufacturer, which involves the use of the integrator, digital readout, and ESAsupplied calibration standards, and the modified procedure, which involves a change in the control settings recommended by the manufacturer.
In the modified procedure, we added a strip-chart recorder and optimized operating conditions to increase sensitivity and permit quantification of Pb concentration by manual measurements of peak height.
Reagents
Metexchange#{174} reagent (ESA) was obtained as prepackaged 2.9-mL tubes of reagent, to be inserted onto the test electrode for analysis. Calibration standards supplied by ESA were also used: these contained reagent, a specified amount of Pb, and 1004 of sonicated human whole blood in aqueous solution. A 2 mg/L Cu solution was purchased from ESA. We prepared additional Pb standards with reagent-grade Pb nitrate (Fisher; cat. no. L62-100) in distilled de-ionized water. The ID-MS analysis for Pb in human and bovine whole blood obtained from Pb-exposed workers and experimental animals was performed by W. I. Manton, Dallas, TX. A series of these samples, selected to represent a range of Pb concentrations, was used as standards (7). We used these blood standards rather than the calibration standards supplied by the manufacturer, to derive the calibration curve. Blood samples of known Pb content were obtained through participation in the Centers for Disease Control (CDC, Atlanta, GA 30333) and Pennsylvania State Department of Health (Penn)2 Blood Lead Proficiency Programs.
Procedures
Glassware cleaning. To remove contaminants from glassware used in these experiments, we first cleaned it in dishwashing detergent, then rinsed it with distilled deionized water. After soaking glassware overnight in a 200 mLIL nitric acid bath, we again rinsed it thoroughly with water and stored it in a closed cabinet until needed.
Sample collection. Blood samples were obtained from human volunteers. Subjects were prepared by scrubbing the puncture site with two separate alcohol swabs. Sterile gauze sponges were used to dry the area after the alcohol cleanings. Venous blood was collected into evacuated tubes tripotassium salt of EDTA. We used Eppendorf pipets for sample transfer and dilutions.
Sample preparation. Precautions taken to avoid Pb contamination during the preparation of samples included performing these operations under a class 100 filtered-air hood. The five blood standards used ranged in concentration from 40 to 500 gfL. All sampleswere routinely analyzed in duplicate. Using the following procedures, we prepared whole-blood samples and standards for analysis in the 3010A instrument:
#{149} Gently mix the samples for 30 mm on an orbital mixer. #{149}Use tissues (Kimwipes#{174}) when removing stoppers from the blood-collection tubes and caps from reagent containers, to minimize contamination.
#{149} Transfer 1004
of sample to the reagent tube, and rinse the pipet tip five or six times with the reagent.
#{149} Recap the reagent tubes and invert, without shaking, three or four times.
Let the blood-reagent mixture stand at room temperature at least overnight to achieve complete decomplexing of the Pb.
Analysis
of samples. Place the sample tubes on the instrument's mercury-coated electrode and stir for 10 s before initiating the analysis. Include a set of five standards at the beginningof the run and after every 30 unknowns. A sample can be contaminated through carryover from the mercury electrode after a high-PbB sample (>200 pg/L) has been analyzed. To avoid this we used a previously analyzed blood-Metexchange mixture known to contain <100 pg of Pb per liter to rinse the electrode. The electrode can also exhibit a "memory" effect; i.e., after analysis of a high-Pb sample, even with a rinse, the next analysis can overestimate the true Pb concentration. Therefore, after analysis of a sample containing Pb >500 pg/L, we perform a 1-mm analysis on a low blood-Metexchange sample to release all the Pb from the electrode.
Calculations. We derive concentration from the integrator and digital monitor display when using the manufacturer's protocol. For the modified method, we measure peak heights. To determine the height, use the point of intersection of the baseline with the front of the peak and then measure the distance vertically to the tip of the peak (Figure   1 ). This 
Results and Discussion
We first evaluated performance by the Model 3010A under recommended operating conditions by analysis of blood samples provided by the CDC and Penn State PbB Proficiency Programs. Regression analysis of results with the Model 3010A with these samples from proficiencytesting programs indicated that PbB values in the range of 30-1120 ,u.g/Lconsistently showed bias (Table 2) . That is, for samples from both programs a slope appreciably different from 1 was obtained. Values >500 pgfL were consistently overestimated, values <300 pg/L consistently underestimated. Furthermore, integrator response values below zero could be duplicated to within ± 10 pg/L, thus indicating good precision of the method but obviously not good accuracy. To In addition, we observed lower-than-expected values for Pb when analyzing samples containing high Cu concentrations such as are seen in blood samples from pregnant women. Women near the end of term have a higher Cu concentration than is usually found in adult women or in children (8). This large Cu peak can overlap the preceding Pb peak. An additional complicating factor arises from the metal-exchange reagent that is used to lyse the erythrocytes and release the Pbfor plating. This solution contains, per liter, 10.7 g of chromium chloride, 14.3 g of calcium acetate, 28 mg of mercuric ion, acids, and a surfactant. Florence and Batley (9) observed that chloride solutions containing Cu appear to contribute significantly to the broadening of the Cu peak. Pinchin and Newham (10) asserted that, in the presence of chloride, Cu peaks appeared to have a steeper slope on the anodic side and to have an asymmetric shape with a shallow slope on the cathodic side. They (10) also showed a progressive cathodic shift in peak potential with increasing chloride and Cu concentrations.
The following study indicates a definite interference from Cu when Pb is determined by use of the integration method of the manufacturer. The Cu concentration of serum from a woman 32 weeks pregnant was 1380 pg/L. Using this blood specimen, with additions of Pb nitrate, we prepared a standard curve. As previously seen, the instrument underes- was increased. The Pb determined via atomic absorption was 80 g/L; the PbB concentration determined by the manufacturer's ASV 3010A method was -20 ,ug/L. By the modified method the value was 75 zgfL We also see this interference when increasing amounts of Cu are added to manufacturer-supplied calibration standards; i.e., a lowerthan-expected Pb concentration will be displayed by the instrument (see Table 3 ).
Underestimates of true PbB were more frequent when blood from pregnant women was evaluated by use of the s0 250 150 50 integrator method. The ionization potential at which Cu is stripped from the electrode immediately follows the potential at which Pb is stripped. Owing to the system used for calculating Pb concentration, an increased Cu concentration can interfere with proper estimation of Pb peak area by the integrator, thus lowering the calculated Pb concentration. This problem is corrected via our modified procedure. With the change in the sweep-rate parameter, the Pb and Cu peaks become more clearly separated, thereby allowing for peak-height measurement. Also, the method for evaluating peak height eliminates use of the point at which the Pb peak returns to baseline.
Biases in accuracy are corrected with the conversion to the modified operating conditions indicated in Table 1 . Table 2 shows improved accuracy in the CDC and Penn State Proficiency Programs. Calibration curves using the ID-MS-determined blood standards and the modified method were found to be linear from 0 to 1000 .&g/L (results not shown). Higher concentrations were not investigated. The detection limit was estimated to be 15 tgfL. Table 2 indicates that, even under the modified protocol, results varied depending upon whether comparisons were made on samples provided by the CDC or Penn programs. This is because the target value or concentration of Pb in these samples is determined by interlaboratory consensus, and not by a definitive method such as rn-MS. More fully to ascertain the accuracy of the modified protocol, we analyzed numerous blood samples whose Pb content had been previously determined by rn-MS.These ID-MS standards were incorporated into the overall laboratory quality-assurance program by disguising them as routine samples. Performance in the blind analysis of these ID-MS standard reference samples is shown in Figure 2 . These samples were analyzed over the course of 24 months. The results indicate that one can maintain a high degree of accuracy over an extended time period with the suggested modification in operating procedures.
Additional procedures are also included in our PbB quality-control program to provide a means of detecting technical error, instrument failure, contamination, and a slow and otherwise undetectable drift in accuracy. Precision is a measure of random error, and can be described in terms of repeatability and reproducibility. Repeatability is defined as the agreement between successive results obtained with the same method and material and under the same conditions. Reproducibility,on the other hand, is the agreement between individual results obtained with the same method and material but under different conditions. Conditions may refer to the operator, laboratory, and (or) time. In our laboratory these two components of precision are evaluated by use of different quality-control techniques. Duplicate samples taken from three separate pools of human whole blood are included in the analysis of each daily run of unknowns. These blood pools, with Pb concentration confirmed by ID-MS, permit monitoring of day-to-day accuracy, repeatability, reproducibility, and drift over time. Table 4 summarizes our laboratory's performance in the analysis of four of these human blood pools. As virtually no amount of scatter or persistent displacement of the results over time was detected, stability of standards and reagents and proper analyst and instrument performance were confirmed. A visual record or laboratory control chart of these daily reference data is provided for early detection of problems.
Other ID-MS samples and proficiency blood samples are submitted at various times to the analyst under fictitious Figure 2 illustrates the results for these blind analyses. From these data, valid estimates of method accuracy can be obtained over time. This procedure is superior to the use of standard reference material, because the analyst not only is unaware of the sample'sPbBvalue but also of its inclusion in the batch of unknowns. Frequently, duplicate Vacutainer Tubes of blood are collected from one volunteer and submitted to the laboratory under two separate guises. The identity of these duplicates is completely unknown to the laboratory personnel and therefore this constitutes another blind scheme for analyses and measurement of precision.
Participation in the CDC and Penn Blood Lead Proficiency programs can provide a continual systematic means of assessing analytical performance (11). These blind qualitycontrol programs provide three (CDC) to four (Penn) blood samples for analysis, on a monthly (CDC) or quarterly (Penn) basis. The results are compared with those generated from several designated reference laboratories, as well as more than 100 participant laboratories. Owing to their limited number of monthly samples, the restricted blood Pb range of the samples, and reliance on interlaboratory consensus for estimation of Pb content, these programs alone are not sufficient to maintain a high level of quality assurance. Consequently, duplicates from 10% of our pediatric samples are also sent to ESA Laboratory Inc. for independent confirmation of PbB. These data anchor our laboratory to another laboratory that processes large numbers of blood samples for Pb determination. The utilization of this combination of quality-control features in a PbB analysis program gives us much confidence in the reliability and quality of the PbB measurements.
We have considered here the specificity and applicability of a PbB method in our laboratory. Measurement of PbB on the ESA analyzer and under the direction of the manufacturer is indeed precise. Its application for screening purposes may also be adequate. However, the suggested modifications to the use of the 3010A instrument definitely improve accuracy while maintaining the precision of the former method. Consequently, the instrument can be used not only 2.2 for screening but also for research purposes. Although relatively expensive, ID-MS-determined blood standards 10:0 should be used. Due to the elimination of ESA calibration standards, cost per analysis is actually reduced. The changes in procedure developed in this study require greater skill and longer analysis time, but in sacrificing ease and speed, improved accuracy is acquired. Validation of results is demonstrated by meeting established standards outlined in a quality-assurance program.
